AMICOAT BOARD OF DIRECTORS

• 

  GERT W. MUNTHE

  CHAIRMAN OF THE BOARD

  

  GERT W. MUNTHE

  CHAIRMAN OF THE BOARD

  Munthe is the founder and Managing Partner of Herkules – a leading Nordic private equity player. Munthe has more than 20 years’ experience as a senior executive from both Norwegian and international business. He was CEO of Alpharma 1998-2000, listed on the NYSE. He was CEO of NetCom in the period 1993 to 1998 and led the company to profitability four years after commercial launch. Prior to NetCom, he was Executive Vice President of Hafslund Nycomed and then CEO of Nycomed Imaging from 1988 to 1993. From 1983 to 1987 he worked for McKinsey & Company in Oslo and New York. Munthe was responsible for Pronova investments in Herkules. Pronova turned to be the world’s leading supplier of Omega 3-based drugs. Munthe has extensive board experience. Munthe holds a degree in economics and statistics from the University of Oslo, and an MBA and an MIA (Master of International Affairs) from Columbia University in New York.

• 

  NINA BAKE

  MEMBER OF THE BOARD

  

  NINA BAKE

  MEMBER OF THE BOARD

  Nina Bake, based in Stockholm, has been head of Telia’s investment in Digital Health, Division X, for the last 4 years.

  Nina was previously an entrepreneur and CEO of the medical technology company Episurf Medical AB, listed on the Stockholm Stock Exchange. Nina has extensive experience from leading positions in startup companies (from idea to commercial launch and listings) in the medical technology and digital health industry both as an entrepreneur and as an intrapreneur. She has a master’s degree in industrial engineering and economics and graduated from Chalmers School of Entrepreneurship, one of the world’s most recognized e-schools.

  Nina is a certified board member and holds a couple of board assignments where she sits as chairman of the company S2Medical aB, listed on First North Growth Market. Nina also holds a board position in the Canada-based digital health company Care Simple Inc.

• 

  KNUT EIDISSEN

  MEMBER OF THE BOARD

  

  KNUT EIDISSEN

  MEMBER OF THE BOARD

  Eidissen is the owner and managing director of the consulting and investment company Picasso AS. Eidissen started his entrepreneurial career when he started the company in 2005, which he has gradually built up to become one of the largest private investment companies in Northern Norway. He has experience as a board member from both private as well as public limited companies. Eidissen has a good track record in creating shareholder value, e.g. as chairman of the oil-and oil service company, Altinex ASA, listed at the Oslo Stock Exchange. Altinex ASA was later acquired by Norwegian Energy Company ASA (Noreco). Eidissen is through Picasso Kapital AS, the largest shareholder in Lytix Biopharma AS.

• 

  ERIK ROSEN

  MEMBER OF THE BOARD

  

  ERIK ROSEN

  MEMBER OF THE BOARD

  Rosen is partner with the law firm Advokatfirmaet Nova. In addition to his education in law at the University of Bergen he holds a MSc in economics from the Norwegian School of Economics and is a Certified European Financial Analyst. Rosen has been Attorney-at-Law with the law firm Advokatfirmaet BAHR and inhouse lawyer with the pharmaceutical company Nycomed. He has also held the position as CEO in two tech companies and is currently chairman/member of several Boards of Directors. High tech SMEs is the focus area of his business. In his law practice he is specialised in contract- and corporate law, M&As included. Rosen’s combined background from management and legal advisory services makes him a sought-after sparring partner for leaders and an esteemed problem solver in negotiations. Rosen is also chairing the humanitarian foundation Art for Change.

• 

  MATHIAS DOKKAN-THORSEN

  MEMBER OF THE BOARD

  

  MATHIAS DOKKAN-THORSEN

  MEMBER OF THE BOARD

  Mathias Dokkan-Thorsen is Investment Manager for Kistefos. Prior to Kistefos, Mathias worked as an Investment Analyst in a PE start-up. His previous experience includes PwC’s valuation and financial modelling practice and four years as an equity analyst in Handelsbanken. Mathias holds a MSc in Business and Economics with a major in Finance from the Norwegian Business School. Mr. Dokkan-Thorsen represents Kistefos on the following boards: Semine, Rubus, Previwo and Amicoat. Beyond mentioned boards Mathias is part of the investment team for: Hjemmelegene and Oslo Airport City.